imatinib mesylate has been researched along with Peripheral Nerve Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beckett, R; Kumari, S; Sherriff, JM; Spooner, D | 1 |
| Berenguer-Potenciano, M; Camacho-Salas, A; Nunez-Enamorado, N; Perez-Alonso, V; Simon-De Las Heras, R; Villora-Morcillo, N | 1 |
| Ross, DM | 1 |
| Chakupurakal, G; Etti, RJ; Murray, JA | 1 |
4 other study(ies) available for imatinib mesylate and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Peripheral neuropathy induced by red yeast rice in a patient with a known small bowel gastrointestinal tumour.
Topics: Antineoplastic Agents; Benzamides; Biological Products; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Intestine, Small; Male; Middle Aged; Peripheral Nervous System Diseases; Piperazines; Pyrimidines | 2013 |
[Therapeutic response to pyridoxine and pyridostigmine in a paediatric case of severe peripheral and cranial polyneuropathy due to vincristine].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blepharoptosis; Cranial Nerve Diseases; Daunorubicin; Diagnosis, Differential; Esotropia; Female; Guillain-Barre Syndrome; Humans; Imatinib Mesylate; Infant; Peripheral Nervous System Diseases; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyridostigmine Bromide; Pyridoxine; Quadriplegia; Vincristine | 2015 |
Peripheral neuropathy on imatinib treatment for chronic myeloid leukaemia: suspected adverse drug interaction with amlodipine.
Topics: Aged; Amlodipine; Benzamides; Drug Interactions; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Peripheral Nervous System Diseases; Piperazines; Pyrimidines | 2009 |
Peripheral neuropathy as an adverse effect of imatinib therapy.
Topics: Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Peripheral Nervous System Diseases; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Time Factors | 2011 |